Blue Dart Express Limited (NSE:BLUEDART)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	141,053	145,774	146,637	147,207	162,373	132,286
Market Cap Growth	-19.80%	-0.59%	-0.39%	-9.34%	22.74%	156.54%
Enterprise Value	145,555	152,222	155,107	152,624	171,667	140,753
Last Close Price	5938.00	6110.02	6139.39	6142.97	6755.90	5452.63
PE Ratio	56.92	57.75	48.72	39.73	42.48	129.93
PS Ratio	2.42	2.55	2.78	2.84	3.68	4.02
PB Ratio	9.05	9.35	10.73	12.48	18.62	22.35
P/TBV Ratio	9.39	9.71	11.30	13.30	20.54	25.77
P/FCF Ratio	-	30.29	25.32	101.26	23.70	22.44
P/OCF Ratio	-	19.83	17.32	20.54	18.89	17.63
EV/Sales Ratio	2.50	2.66	2.94	2.95	3.89	4.28
EV/EBITDA Ratio	16.76	24.67	25.66	21.24	22.43	31.05
EV/EBIT Ratio	37.16	37.97	36.36	26.70	28.11	52.27
EV/FCF Ratio	-	31.63	26.78	104.98	25.05	23.87
Debt / Equity Ratio	0.65	0.65	0.79	0.95	1.22	2.57
Debt / EBITDA Ratio	1.16	1.16	1.27	1.18	1.08	2.25
Debt / FCF Ratio	-	2.09	1.85	7.71	1.56	2.58
Asset Turnover	-	1.61	1.58	1.71	1.54	1.19
Inventory Turnover	-	86.36	89.41	105.76	93.45	80.24
Quick Ratio	-	1.05	0.79	0.83	0.78	0.76
Current Ratio	-	1.14	0.86	0.95	0.85	0.84
Return on Equity (ROE)	-	17.25%	23.64%	36.12%	52.22%	18.80%
Return on Assets (ROA)	-	7.03%	7.98%	11.81%	13.33%	6.08%
Return on Capital (ROIC)	9.78%	10.01%	11.24%	16.86%	18.83%	8.27%
Return on Capital Employed (ROCE)	-	17.10%	21.70%	27.10%	39.20%	16.80%
Earnings Yield	1.76%	1.73%	2.05%	2.52%	2.35%	0.77%
FCF Yield	-	3.30%	3.95%	0.99%	4.22%	4.46%
Dividend Yield	0.42%	0.41%	0.41%	0.49%	0.89%	0.27%
Payout Ratio	-	23.50%	23.65%	22.41%	24.83%	-
Total Shareholder Return	0.44%	0.41%	0.41%	0.49%	0.89%	0.27%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.